Results 1 to 10 of about 68,062 (177)

Clinicopathological Features and Prognosis of Pediatric Mastocytosis: A 15-Year Experience with Emphasis on Disease Evolution [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Qiannan Jia, Weiqi Wang, Shuaixin Li, Xinran Li, Aiping Fan, Dian Zheng, Siying Li, Jun LiDepartment of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and ...
Jia Q   +7 more
doaj   +2 more sources

Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis [PDF]

open access: yesExperimental Hematology & Oncology
Advanced systemic mastocytosis (AdvSM), comprising aggressive systemic mastocytosis, mast cell leukemia, and systemic mastocytosis with an associated hematological neoplasm, is a heterogeneous myeloid neoplasm with poor prognosis.
Stefan Haug   +63 more
doaj   +2 more sources

Systemic Lymphadenopathic Mastocytosis with Eosinophilia

open access: yesDiagnostics, 2022
Systemic mastocytosis is a neoplastic proliferation of mast cells that most frequently involves cutaneous sites. Mastocytosis involves various extracutaneous sites, but the lymph node is rare.
Soyoung Im   +3 more
doaj   +1 more source

Mastocytosis. General concepts, view on patient management, examples of clinical course of the disease

open access: yesZdorovʹe Rebenka, 2022
Background. Mastocytosis is a disease characterized by the presence of mast cells in various organs. The skin is affected most often. Almost every patient diagnosed with mastocytosis has skin lesions.
O.L. Statkevych, T.V. Sviatenko
doaj   +1 more source

SWATH-MS identification of CXCL7, LBP, TGFβ1 and PDGFRβ as novel biomarkers in human systemic mastocytosis

open access: yesScientific Reports, 2022
Mastocytosis is a rare myeloproliferative disease, characterised by accumulation of neoplastic mast cells in one or several organs. It presents as cutaneous or systemic.
R. L. J. Graham   +5 more
doaj   +1 more source

Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications

open access: yesItalian Journal of Pediatrics, 2023
Background Pediatric Mastocytosis is a rare and heterogeneous disease, characterized by accumulation of mast cells in the skin (Cutaneous Mastocytosis) and/or, less frequently, in other organs, mainly liver, spleen, bone marrow, lymph nodes and ...
Grazia Bossi   +9 more
doaj   +1 more source

Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. [PDF]

open access: yesPLoS ONE, 2008
Adult's mastocytosis is usually associated with persistent systemic involvement and c-kit 816 mutation, while pediatrics disease is mostly limited to the skin and often resolves spontaneously.
Fanny Lanternier   +26 more
doaj   +1 more source

Delayed Diagnosis of Indolent Systemic Mastocytosis as the Cause of Unexplained Skin Rash: A Case Report

open access: yesCase Reports in Oncology, 2023
Mastocytosis is a heterogeneous group of disorders in which mast cells exhibit clonal proliferation that infiltrates one or more organs. In cutaneous mastocytosis, the mast cells infiltrate the skin only, whereas systemic mastocytosis is diagnosed when ...
Awni Alshurafa   +4 more
doaj   +1 more source

How “benign” is cutaneous mastocytosis? A Danish registry-based matched cohort study

open access: yesInternational Journal of Women's Dermatology, 2020
Background: There are limited estimates of the incidence rates (IRs) of mastocytosis, and only a few studies have addressed the long-term consequences of living with these diagnoses.
Line Kibsgaard, MD, PhD   +5 more
doaj   +1 more source

Recalcitrant Cutaneous Mastocytosis Treated With Genetically Informed Targeted Therapy: A Case Report

open access: yesInternational Journal of Dermatology and Venerology, 2023
Introduction:. Mastocytosis, a clonal proliferation of mast cells commonly involving the skin and bone marrow, has a varied clinical presentation ranging from cutaneous lesions to systemic disease.
Laura Gleason   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy